drugset / Trial / NCT00972725

Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose

NCT00972725

Phase 2 Completed 28 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the safety and reactogenicity of one booster dose of a HIV candidate vaccine after administration of one oral dose of chloroquine.

Timeline

Start
2009-12-01
Primary completion
2010-10-04
Completion
2010-10-04

Drugs

EvaluationDrugModalityDoseRoute
Subject 732461 Vaccine Intramuscular
Subject Chloroquine Small molecule 300 mg Oral

Indications